Anti-GP2 IgA: a biomarker for disease severity and/or cholangiocarcinoma in primary sclerosing cholangitis?

Rizvi Sumera; Yang Ju Dong; Gores Gregory J.

首页> 外文期刊>Gut: Journal of the British Society of Gastroenterology >Anti-GP2 IgA: a biomarker for disease severity and/or cholangiocarcinoma in primary sclerosing cholangitis?

【24h】

Anti-GP2 IgA: a biomarker for disease severity and/or cholangiocarcinoma in primary sclerosing cholangitis?

机译：抗GP2 IgA：疾病严重程度和/或胆管炎胆囊炎的生物标志物？

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Gut: Journal of the British Society of Gastroenterology》 |2017年第1期|共2页
作者
Rizvi Sumera; Yang Ju Dong; Gores Gregory J.;
展开▼
作者单位

Mayo Clin Div Gastroenterol &

Hepatol 200 First St SW Rochester MN 55905 USA;

Mayo Clin Div Gastroenterol &

Hepatol 200 First St SW Rochester MN 55905 USA;

Mayo Clin Div Gastroenterol &

Hepatol 200 First St SW Rochester MN 55905 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Anti-GP2 IgA: a biomarker for disease severity and/or cholangiocarcinoma in primary sclerosing cholangitis? [J] . Rizvi Sumera, Yang Ju Dong, Gores Gregory J. Gut: Journal of the British Society of Gastroenterology . 2017,第1期

机译：抗GP2 IgA：疾病严重程度和/或胆管炎胆囊炎的生物标志物？
2. Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis [J] . Jendrek Sebastian Torben, Gotthardt Daniel, Nitzsche Thomas, Gut: Journal of the British Society of Gastroenterology . 2017,第1期

机译：抗GP2 IgA自身抗体与原发性胆管炎的存活率和胆管癌不良有关
3. Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis [J] . Banales Jesus M., I?arrairaegui Mercedes, Arbelaiz Ander, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2019,第2期

机译：血清代谢物作为胆管癌，肝细胞癌和原发性硬化性胆管炎的诊断生物标志物
4. Hepatocellular carcinoma, cholangiocarcinoma, colon and pancreatic carcinoma in patients with primary sclerosing cholangitis: epidemiology and risk factors [C] . U. BROOME, A. BERGQUIST Falk Liver Week . 2004

机译：肝细胞癌，胆管癌，结肠癌和初级硬化性胆管炎患者的胰腺癌：流行病学和风险因素
5. Predicting outcomes post liver transplantation in patients with primary biliary cirrhosis and primary sclerosing cholangitis. [D] . Zapatochny Rufo, Rebecca Jo. 2003

机译：预测原发性胆汁性肝硬化和原发性硬化性胆管炎患者肝移植后的结局。
6. Anti-GP2 IgA: a biomarker for disease severity and/or cholangiocarcinoma in primary sclerosingcholangitis? [O] . Sumera Rizvi, Ju Dong Yang, Gregory J Gores -1

机译：抗GP2 IgA：原发性硬化中疾病严重程度和/或胆管癌的生物标志物胆管炎？
7. IgG4-Related Sclerosing Cholangitis in the Absence of Autoimmune Pancreatitis Mimicking Extrahepatic Cholangiocarcinoma: A Comparison Study With Extrahepatic Cholangiocarcinoma, Primary Sclerosing Cholangitis, and Secondary Sclerosing Cholangitis [O] . Jingmei Lin 2014

机译：IgG4相关的胆管炎在没有自身免疫性胰腺炎的情况下模仿嗜肺胆管癌：对肠外胆管癌，原发性胆管炎和继发性胆管炎的比较研究

Anti-GP2 IgA: a biomarker for disease severity and/or cholangiocarcinoma in primary sclerosing cholangitis?

著录项

引文网络

相似文献

相关主题

期刊订阅